Hot Keywords
Non-small cell lung cancer Artificial intelligence Gastroesophageal reflux Esophagectomy Thoracic surgery Atherosclerosis Robotic surgery Gastric cancer Lung cancer Lobectomy Complications Quality of life Rectal cancer

Mini-invasive Surg 2021;5:[Accepted].10.20517/2574-1225.2021.45@The Author(s) 2021
Accepted Manuscript
Open AccessReview

Hybrid coronary revascularization: the Emory experience

Correspondence Address: Dr. Michael E. Halkos, Division of Cardiothoracic Surgery, Department of Surgery, Emory University, 1364 Clifton Road, Atlanta, GA 30322, USA. E-mail: mhalkos@emory.edu


© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.


This article reviews the Emory University Experience with hybrid coronary revascularization and identifies key factors essential for the success of this relatively new and evolving strategy for the treatment of coronary artery disease. Key decisional and technical factors were identified. Careful patient selection, stepwise progression in learning the different aspects of the procedure, and close collaboration between cardiac surgery-interventional cardiology are key factors for success.

Cite This Article

Pusca SV, Halkos ME. Hybrid coronary revascularization: the Emory experience. Mini-invasive Surg 2021;5:[Accept]. http://dx.doi.org/10.20517/2574-1225.2021.45

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties